dc.creator | Ruiz Carnicer, Ángela | es |
dc.creator | Segura Montero, Verónica | es |
dc.creator | Sousa Martín, Carolina | es |
dc.creator | Comino Montilla, Isabel María | es |
dc.date.accessioned | 2022-06-30T14:05:59Z | |
dc.date.available | 2022-06-30T14:05:59Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Ruiz Carnicer, Á., Segura Montero, V.,...,Comino Montilla, I.M. (2022). Celiac Disease, Management, and Follow-Up. En Immunology of the GI Tract (pp. 1-23). Intechopen. | |
dc.identifier.uri | https://hdl.handle.net/11441/134867 | |
dc.description.abstract | Celiac disease (CD) is a systemic immune-mediated disorder characterized by
a specific serological and histological profile triggered by gluten ingestion, which
is given in genetically predisposed subjects. Heterogeneous clinical presentation
is characteristic in CD, affecting any organ or tissue with gastrointestinal,
extraintestinal, seronegative, or nonresponsive manifestations. CD diagnosis is based
on several criteria, including genetic and serological tests, clinical symptoms and/or
risk conditions, and duodenal biopsy. Currently, the available treatment for CD is a
strict gluten-free diet (GFD) that essentially relies on the consumption of naturally
gluten-free foods, such as animal-based products, fruits, vegetables, legumes, and
nuts, as well as gluten-free dietary products that may not contain more than 20 mg
of gluten per kg of food according to Codex Alimentarius. However, it is difficult
to maintain a strict oral diet for life and at least one-third of patients with CD are
exposed to gluten. Difficulties adhering to a GFD have led to new tools to monitor the
correct adherence to GFD and alternative forms of treatment. | es |
dc.description.sponsorship | Junta de Andalucía PI-0053-2018 | es |
dc.format | application/pdf | es |
dc.format.extent | 23 p. | es |
dc.language.iso | eng | es |
dc.publisher | Intechopen | es |
dc.relation.ispartof | Immunology of the GI Tract | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Celiac disease | es |
dc.subject | Gluten-free diet | es |
dc.subject | Gluten immunogenic peptides | es |
dc.subject | Dietary adherence | es |
dc.subject | Non-dietary therapies | es |
dc.title | Celiac Disease, Management, and Follow-Up | es |
dc.type | info:eu-repo/semantics/bookPart | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Microbiología y Parasitología | es |
dc.relation.projectID | PI-0053-2018 | es |
dc.relation.publisherversion | https://dx.doi.org/10.5772/intechopen.104652 | es |
dc.identifier.doi | 10.5772/intechopen.104652 | es |
dc.publication.initialPage | 1 | es |
dc.publication.endPage | 23 | es |
dc.contributor.funder | Junta de Andalucía | es |